Abstract: Producing a composition comprising cells of at least one bacterium, where at least 90% of the composition is in the form of a free flowing powder, by providing a drum dryer comprising two spaced-apart rotatable cylinders, with a gap of width G inches and a length of L inches therebetween; providing a fermentation broth comprising cells of at least one bacterium in a liquid suspension at a total solid content C percent weight of no greater than about 15% wt of the total weight of the fermentation broth; and introducing the fermentation broth into said drum dryer at a rate of W Kg per hour of no greater than 14×[(G×L)/C] to provide the composition.

Abstract: Provided is a method for producing an ester of butyric acid from an acid mixture, comprising contacting an aqueous carboxylic acid mixture comprising butyric acid and at least one additional carboxylic acid selected from the group consisting of formic acid, acetic acid, propionic acid, lactic acid, hydroxybutyric acid and combinations thereof, wherein at least 30% of the total amount of acids in the aqueous carboxylic acid mixture are in free acid form, with a liquid extractant having a Hildebrand solubility parameter of less than 25 MPa(1/2); separating a resultant butyric acid-comprising extract from a residual aqueous phase; contacting a resultant separated butyric acid-comprising extract with an alkanol in the presence of an acid catalyst, to form a product comprising an ester of butyric acid and alkanol and optionally water; wherein when water is formed, separating water to provide a separated product comprising an ester of butyric acid.

Abstract: A composition of at least one cannabinoid, at least one terpene of pinene, limonene, linalool, caryophyllene, myrcene, humulene, terpineol, nerolidol, bisabolol, geraniol, borneol, eucalyptol in a concentration of at least about 20 wt % of terpenes in the composition, or at least two terpenes in a combined amount of at least about 40 wt % of terpenes in the composition, at least 5% by weight of a non-cannabinoid, non-terpene carrier, less than 5% by weight glycol, and less than 20% by weight water, and where the non-cannabinoid, non-terpene carrier comprises a) at least 5% by weight cellulose and the total terpenes to total cannabinoids weight/weight ratio in the composition is from 0.1 to 1.0, or b) less than 5% by weight cellulose and the total terpenes to total cannabinoids weight/weight ratio is from 0.05 to 1.0, obtained by providing and blending the cannabinoid and terpene in amounts configured to provide the ratio.

Abstract: A composition of at least one cannabinoid in a specific amount, and at least one primary terpene in a specific amount, where a total terpenes to total cannabinoids weight/weight ratio in the composition is from about 0.05 to about 1.0.

Abstract: Provided is food component comprising cells of at least one bacterium, said cells comprising a crude protein concentration of at least 60 wt % of a total dry weight of said cells and nucleic acid at a concentration of less than about 5 wt % of a total dry weight of said cells, wherein at least 50% of a total number of said cells are dead cells. Further provided are food and beverages comprising such food components and methods of manufacture thereof.

Abstract: Provided is a feed ingredient comprising propionate and a byproduct of fermentation of a feedstock by propionic acid-producing bacteria, wherein said feedstock comprises a carbon source and wherein said bacteria are of a class selected from the group consisting of Actinobacteria, Bacteroidia, Clostridia, Negativicutes and combinations thereof. Also provided are methods for manufacturing the feed ingredient and uses thereof.

Abstract: A cannabis-enriched enzymatically treated therapeutic composition. A therapeutic composition is described including water, glucose, glucose reaction product other than sucrose and fructose; a selected amount of a cannabinoid, a cannabinoid reaction product; optionally a terpene and optionally a terpene reaction product. Methods of making and using the compositions are also described.

Abstract: Provided is food component comprising cells of at least one bacterium, said cells comprising a crude protein concentration of at least 60 wt % of a total dry weight of said cells and nucleic acid at a concentration of less than about 5 wt % of a total dry weight of said cells, wherein at least 50% of a total number of said cells are dead cells. Further provided are food and beverages comprising such food components and methods of manufacture thereof.

Abstract: A therapeutic product comprising at least one cannabinoid, at least one primary terpene, and at least 5% by weight of a non-cannabinoid, non-terpene carrier, wherein said non-cannabinoid, non-terpene carrier comprises cellulose and the terpenes to cannabinoids weight/weight ratio in said product is about 0.1 to about 1.0; a method of treating certain conditions and/or symptoms in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a product comprising at least one primary terpene; a therapeutic product comprising a primary terpene blend, wherein said primary terpene blend comprises five or less terpenes, and wherein each one of those terpenes, where present, independently comprises at least 10% of the total terpene content.

Abstract: A composition of at least one cannabinoid in a specific amount, and at least one primary terpene in a specific amount, where a total terpenes to total cannabinoids weight/weight ratio in the composition is from about 0.05 to about 1.0.

Abstract: Provided are compositions comprising at least one organism of a strain of the order Clostridiales and methods of use thereof for protecting against an infection, such as a viral, protozoal or fungal infection in an animal. Also provided are methods for improving hatchability of an egg under contaminated conditions by protecting against infection of an avian in ovo.

Abstract: Provided is a composition comprising at least one selected fragment of DNA exogenous to a targeted organism and a carrier, wherein said DNA fragment has at least 50% sequence homology to a DNA sequence of said targeted organism and wherein said fragment comprises no more than 5 unprotected specific endonuclease recognition sites of said targeted organism. Further provided are methods of use of the composition. Further provided are methods for producing the composition.

Abstract: Provided are microbial compositions comprising at least one attenuated form of a pathogenic bacterium having an ability to colonize at least one organ of the gastrointestinal tract of an animal, such as an attenuated form of a bacterium having an antagonistic effect against a bacterium selected from the group consisting of Salmonella enteritidis, Salmonella enterica, Salmonella typhimurium, lostridium difficile, Clostridium perfringens, Escherichia coli, Campylobacter spp., Listeria monocytogenes, Yersinia enterocolitica and combinations thereof. Also provided are animal feeds comprising such compositions, preparations for in-ovo injection comprising such compositions and methods of treatment using such compositions.

Abstract: Provided is a therapeutic product comprising at least one cannabinoid; at least one primary terpene; and at least 5% by weight of a non-cannabinoid, non-terpene carrier, wherein said non-cannabinoid, non-terpene carrier comprises cellulose and the terpenes to cannabinoids weight/weight ratio in said product is about 0.1 to about 1.0. Also provided is a method of treating certain conditions and/or symptoms in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a product comprising at least one primary terpene. Further provided is a therapeutic product comprising a primary terpene blend, wherein said primary terpene blend comprises five or less terpenes, and wherein each one of those terpenes, where present, independently comprises at least 10% of the total terpene content.

Abstract: Provided are aqueous fermentation feedstocks comprising glucose monomers at a concentration of less than 50 gram/Liter (g/L) of the total feedstock, water-soluble dextrose oligomers at a concentration in a range between 50 g/L and 300 g/L of the total feedstock; and water. Further provided are methods of production thereof and uses thereof in the production of single cell protein and/or ethanol.

Abstract: Methods for the production of different cannabis product compositions. Method for the production of at least two different cannabis product compositions from a solid cannabis plant material are described including providing a solid cannabis plant material containing at least one cannabinoid and at least one terpene at cannabinoid to terpene weight/weight ratio R100; first extracting from said solid cannabis plant material a first composition comprising at least 10% but less than 90% of said cannabinoid and at least 1% of said terpene at cannabinoid to terpene weight/weight ratio R101, wherein R101 differs from R100 by at least 10%; second extracting from said solid cannabis plant material a second composition comprising at least 10% of said cannabinoid and at least 1% of said terpene at cannabinoid to terpene weight/weight ratio R102, wherein R102 differs from R101 by at least 10%; and optionally refining said first composition, said second composition, or both.

Abstract: Provided is a probiotic composition, comprising at least one genus of mixotrophic microorganism and a carrier and pharmaceutical preparations comprising such a composition for use in the treatment of bloating in an animal. Also provided are methods of use of such pharmaceutical preparations in the treatment of bloating in an animal.

Abstract: Terpene-ensiched cannabinoid composition. Cannabinoid compositions are described including at least one cannabinoid in a specific amount, a primary terpene in a specific amount, at least 5% by weight of a non-cannabinoid, non-terpene, carrier, optionally at least three secondary terpenes; less than 5% by weight glycol; and less than 20% by weight water, where said non-cannabinoid, non-terpene carrier comprises cellulose and the terpenes to cannabinoids weight/weight ratio in said composition is about 0.1 to about 1.0. Also described are the above compositions where said non-cannabinoid, non-terpene carrier comprise less than 5% by weight cellulose and the terpenes to cannabinoids weight/weight ratio in said compositions is about 0.05 to about 1.0, forming terpene-enriched cannabinoid compositions with enhanced therapeutic effect compared with that of a composition comprising the same cannabinoids amounts and one half the amount of said primary terpene.

Abstract: Supplemented mixotrophic method. A mixotrophic fermentation method is disclosed including providing a naturally acetogenic organism; providing a fermentation medium comprising a carbon source and a supplemented non-sugar reductant; and culturing the organism in the fermentation medium, where both the carbon source and the non-sugar reductant are metabolized and a fermentation broth is formed, which contains at least one carbon-containing bioproduct.

Abstract: Provided are methods and compositions an organism of the order Clostridiales for improving the health of an avian, wherein an effective dose of the composition is applied to an outer surface of an egg containing the avian as an embryo prior to hatching. Also disclosed are compositions comprising a strain within the order Clostridiales selected from the group consisting of Caldicoprobacteraceae; Christensenellaceae; Clostridiaceae; Defluviitaleaceae; Eubacteriaceae; Graciibacteraceae; Heliobacteriaceae; Lachnospiraceae; Oscillospiraceae; Peptococcaceae; Peptostreptococcaceae; Ruminococcaceae; Syntrophomonadaceae and combinations thereof and their use in such methods.